Pan Tumour Nivolumab Rollover Study

Official Title

Pan-Tumour Study for Long Term Follow-up of Cancer Survivors Who Have Participated in Trials Investigating Nivolumab

Summary:

Main Objective of this study is to examine long-term safety of nivolumab in participants on treatment and in follow up.

Trial Description

Primary Outcome:

• Incidence of Adverse Events (AEs)
• Incidence of drug related AEs
• Incidence of AEs leading to Discontinuation
• Incidence of Serious Adverse Events (SAEs)
• Incidence of Select AEs
• Incidence of Immune-Mediated AEs
• Incidence of Death

View this trial on ClinicalTrials.gov